Belpointe Asset Management »

Vaneck Vectors Pharmaceutical etf shares owned by Belpointe Asset Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Belpointe Asset Management from 13F filings

Historical chart of Belpointe Asset Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Belpointe Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Belpointe Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $835k 8.1k 103.17
2025-09-30 $733k 8.1k 90.36
2025-06-30 $502k 5.7k 87.96
2025-03-31 $528k 5.8k 91.13
2023-03-31 $9.3k 120 77.63
2022-12-31 $22k 287 77.82

More positions owned by Belpointe Asset Management

Servicenow (NOW)
SPDR S&P 500 Etf (SPY)
Invesco Qqq Tr Etf (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Schwab Strategic Tr Etf (SCHG)
Anydrus Advantage Etf Etf (NDOW)
Collaborative Investmnt Ser Etf (PLGI)
Microsoft Corporation (MSFT)
Collaborative Investmnt Ser Etf (NELS)
Schwab Strategic Tr Etf (SCHX)
Sch Fnd Us Lg Etf schwb fdt us lg (FNDX)
Vanguard Index Fds Etf (VOO)
Amazon (AMZN)
Vanguard Index Fds Etf (VUG)

View all positions for Belpointe Asset Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Bnp Paribas Arbitrage, Snc
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Adamsbrown Wealth Consultants
Susquehanna International
UBS Group
LPL Financial

View all funds holding Vaneck Vectors Pharmaceutical etf